These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6277094)

  • 1. Radiosynoviorthesis in haemophilic joint disease.
    van't Pad Bosch PJ; van de Putte LB; Boerbooms AM; Geerdink PJ
    Z Rheumatol; 1981; 40(6):237-9. PubMed ID: 6277094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of haemophilic synovitis: clinical aspects.
    Hoots WK; Rodriguez N; Boggio L; Valentino LA
    Haemophilia; 2007 Nov; 13 Suppl 3():4-9. PubMed ID: 17822514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The co effect of prophylaxis and radiosynovectomy on bleeding episodes in haemophilic synovitis.
    Brecelj J; Bole V; Benedik-Dolnicar M; Grmek M
    Haemophilia; 2008 May; 14(3):513-7. PubMed ID: 18248407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synoviorthesis with 198Au colloid gold in haemophilia patients. A preliminary report.
    Ortonowski G; Ziemski JM; Kucharski W; Woy-Wojciechowski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):505-10. PubMed ID: 1714852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynoviorthesis for treatment of hemophilic hemarthrosis--Slovenian experience.
    Grmek M; Milcinski M; Fettich J; Benedik-Dolnicar M; Brecelj J
    Cancer Biother Radiopharm; 2005 Jun; 20(3):338-43. PubMed ID: 15989481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of haemophilic synovitis: prophylaxis.
    Lee CA
    Haemophilia; 2007 Nov; 13 Suppl 3():20-5. PubMed ID: 17822517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioactive synoviorthesis in patients with hemophilia with factor inhibitor.
    Löfqvist T; Petersson C; Nilsson IM
    Clin Orthop Relat Res; 1997 Oct; (343):37-41. PubMed ID: 9345203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haemophilia and knee function: are there differences between haemophilic and healthy children?].
    Seuser A; Schumpe G; Schuhmacher M; Lehmacher K; Oldenburg J; Berdel P
    Hamostaseologie; 2009 Oct; 29 Suppl 1():S69-73. PubMed ID: 19763348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthopaedic management of haemophilia arthropathy of the ankle.
    Pasta G; Forsyth A; Merchan CR; Mortazavi SM; Silva M; Mulder K; Mancuso E; Perfetto O; Heim M; Caviglia H; Solimeno L
    Haemophilia; 2008 Jul; 14 Suppl 3():170-6. PubMed ID: 18510538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (32)P colloid radiosynovectomy in treatment of chronic haemophilic synovitis: Iran experience.
    Mortazavi SM; Asadollahi S; Farzan M; Shahriaran S; Aghili M; Izadyar S; Lak M
    Haemophilia; 2007 Mar; 13(2):182-8. PubMed ID: 17286772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits].
    Roosendaal G; Lafeber FP
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2606-8. PubMed ID: 18161260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with radiosynoviorthesis in hemophilic patients with and without inhibitor.
    Tena-Sanabria ME; Rojas-Sato YF; Castañeda-Resendiz JC; Fuentes-Herrera G; Álvarez-Martínez FA; Tena-Gonzalez YI; Núñez-Enríquez JC
    BMC Pediatr; 2020 Apr; 20(1):173. PubMed ID: 32312235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying and overcoming barriers to prophylaxis in the management of haemophilia.
    Petrini P
    Haemophilia; 2007 Sep; 13 Suppl 2():16-22. PubMed ID: 17685919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed.
    van Dijk K; Fischer K; van der Bom JG; Grobbee DE; van den Berg HM
    Haemophilia; 2005 Sep; 11(5):438-43. PubMed ID: 16128885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosynoviorthesis of medium-sized joints with rhenium-186-sulphide colloid: a review of the literature.
    Klett R; Lange U; Haas H; Voth M; Pinkert J
    Rheumatology (Oxford); 2007 Oct; 46(10):1531-7. PubMed ID: 17596287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.